🔍 Observations
Topline
- Revenue from operations surged 27.8% YoY (₹7,540 Cr → ₹9,638 Cr), sustaining the company’s multi-year high-growth arc in explosives and defence.
- Q4FY26 revenue hit ₹3,053 Cr — up 40.9% YoY and 19.8% QoQ — signalling strong Q4 seasonality and order execution acceleration.
- Q4 is disproportionately heavy; Q4FY26 alone contributed ~32% of full-year revenue, consistent with prior-year patterns.
Bottomline
- Net profit grew 34.8% YoY (₹1,288 Cr → ₹1,737 Cr); Basic EPS expanded from ₹133.65 to ₹185.39 — a clean 38.7% jump.
- Q4FY26 PAT of ₹856 Cr surged 147% YoY (₹346 Cr Q4FY25) — an outlier quarter; partly driven by tax line movements (note negative deferred tax of ₹0.76 Cr vs. ₹20.52 Cr in Q4FY25).
- Profit growth is outpacing revenue growth, indicating operating leverage is kicking in.
Margins
- Full-year operating margin improved modestly: 23.67% → 24.10% (+43 bps YoY). Net profit margin: 17.08% → 17.65% (+57 bps).
- Q4FY26 operating margin at 24.76% held steady despite a sharp jump in material costs (₹940 Cr → ₹1,435 Cr QoQ), reflecting pricing power and product mix.
- Employee costs grew only 5.6% YoY on a full-year basis (₹800 Cr → ₹845 Cr) against 27.8% revenue growth — strong cost leverage on the fixed-cost base.
Growth Trajectory
- Revenue CAGR implied over two years is substantial; FY26 at ₹9,638 Cr vs FY25 at ₹7,540 Cr vs FY24 (not provided) — but the sequential step-up is large and consistent.
- Depreciation jumped 38.1% YoY (₹182 Cr → ₹251 Cr), reflecting capacity commissioning — growth capex is translating into productive assets.
- Net worth grew 42.2% YoY (₹4,413 Cr → ₹6,277 Cr), driven by retained earnings — balance sheet self-funds growth meaningfully.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Operating leverage is real: Revenue +27.8% YoY while employee costs grew only 5.6% — margin expansion is structurally supported, not one-off.
- Interest coverage is exceptional: ISCR of 30.1x (FY26) vs 15.5x (FY25) — debt is not a financial risk at current earnings levels.
- Capex translating into scale: PPE grew from ₹2,470 Cr to ₹3,716 Cr (+50.5%) with CWIP of ₹592 Cr — capacity pipeline intact for FY27 revenue step-up.
- Debt discipline maintained: Debt-to-equity at 0.23x despite aggressive capex; total debt to assets only 0.13x — fortress balance sheet.
- EPS compounding strongly: Basic EPS at ₹185.39 in FY26 vs ₹133.65 in FY25 — 38.7% growth; re-rating catalyst for premium valuations.
- Defence and exports diversification: NCI and hyperinflationary economy subsidiaries signal meaningful international presence — geographical moat building.
- Current ratio healthy: 2.06x in FY26 — short-term liquidity is comfortable even as working capital has scaled with revenues.
🔴 Red Flags
- Operating cash flow collapsed: OCF fell from ₹2,468 Cr (FY25) to ₹621 Cr (FY26) — a 74.8% drop — despite higher profits. Working capital consumed ₹1,577 Cr net vs generating ₹814 Cr in FY25.
- Receivables surge is alarming: Trade receivables jumped ₹619 Cr YoY (₹1,239 Cr → ₹1,858 Cr), absorbing ₹634 Cr in cash — collections are not keeping pace with billing.
- Inventory build is aggressive: Inventories rose ₹702 Cr YoY (₹1,040 Cr → ₹1,742 Cr) — either a deliberate scale-up bet or demand-pull risk. Inventory turnover deteriorated: 21.19x → 17.0x.
- Free cash flow is deeply negative: Capex of ₹1,739 Cr against OCF of ₹621 Cr yields FCF of approximately -₹1,118 Cr — the company is a net cash consumer in FY26.
- Other current liabilities spike: Rose from ₹428 Cr to ₹674 Cr (+57.5%) — likely advance receipts from defence orders, but warrants monitoring for obligation fulfillment timelines.
- Hyperinflationary economy exposure: ₹94.53 Cr loss adjustment in FY26 (vs ₹65 Cr in FY25) from subsidiaries in hyperinflationary economies — a growing and uncontrollable drag.
- Non-current other assets doubled: ₹236 Cr → ₹442 Cr — capital advances and long-duration receivables are growing; quality of these assets requires scrutiny.
📊 Balance Sheet Analysis
- Asset quality strong at the core: PPE + CWIP at ₹4,308 Cr represents productive, capacity-building assets; goodwill at ₹171 Cr is modest relative to equity of ₹6,277 Cr.
- Leverage remains conservative: Total borrowings (current + non-current) = ₹1,468 Cr against equity of ₹6,277 Cr; D/E of 0.23x leaves ample headroom for further debt-funded capex.
- Working capital has stretched sharply: Combined receivables + inventory = ₹3,600 Cr vs ₹2,279 Cr in FY25 — a ₹1,321 Cr YoY increase; this is the primary balance sheet risk.
- Net worth compounding at 42% YoY — retained earnings are the primary growth capital engine; equity dilution risk is low.
💰 Cash Flow Analysis
- OCF-to-PAT ratio deteriorated severely: OCF of ₹621 Cr vs PAT of ₹1,737 Cr = 35.7% conversion — vs ~191% in FY25. Profit quality is under pressure from working capital build.
- Capex intensity is at peak cycle: ₹1,739 Cr invested in fixed assets in FY26 vs ₹1,006 Cr in FY25 — a 72.9% jump; this is deliberate capacity front-loading for defence and industrial explosives scale-up.
- Financing bridged the gap: Net borrowings raised ₹490 Cr (non-current net: +₹427 Cr; current net: +₹62 Cr) to fund the FCF deficit — balance sheet used prudently, not recklessly.
- Cash position declined modestly: ₹593 Cr → ₹456 Cr (balance sheet) — liquidity buffer intact, but another year of negative FCF would test it.
💡 Investment Outlook
Solar Industries delivered a strong FY26 on the P&L — revenue +27.8%, PAT +34.8%, with margins holding above 24% — driven by explosives volume growth and defence order execution.
The critical watch item is the working capital deterioration: receivables and inventory together absorbed over ₹1,300 Cr in cash, collapsing OCF to ₹621 Cr despite record profits.
The peak capex cycle (₹1,739 Cr in FY26) signals management confidence in a multi-year demand runway, particularly in defence — but investors must track OCF recovery in FY27 as the key re-rating trigger.
If collections normalise and capacity commissioned in FY26 drives operating leverage, FCF inflection could be the next significant catalyst.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.